Verano Holdings Corp
Verano Holdings Corp. operates as a vertically integrated multi-state cannabis operator in the United States. The company engages in the cultivation, processing, wholesale, and retail distribution of cannabis in Arizona, Connecticut, Florida, Illinois, Maryland, Massachusetts, Michigan, Nevada, New Jersey, Ohio, Virginia and West Virginia, and Pennsylvania. It offers cannabis products under the E… Read more
Verano Holdings Corp (VRNOF) - Net Assets
Latest net assets as of June 2025: $925.46 Million USD
Based on the latest financial reports, Verano Holdings Corp (VRNOF) has net assets worth $925.46 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.94 Billion) and total liabilities ($1.02 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $925.46 Million |
| % of Total Assets | 47.66% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 7.06 |
Verano Holdings Corp - Net Assets Trend (2019–2024)
This chart illustrates how Verano Holdings Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Verano Holdings Corp (2019–2024)
The table below shows the annual net assets of Verano Holdings Corp from 2019 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $950.82 Million | -23.33% |
| 2023-12-31 | $1.24 Billion | -7.56% |
| 2022-12-31 | $1.34 Billion | -9.28% |
| 2021-12-31 | $1.48 Billion | +535733.82% |
| 2020-12-31 | $-276.07K | -166.08% |
| 2019-12-31 | $-103.75K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Verano Holdings Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 78192720500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $1.74 Billion | 182.30% |
| Total Equity | $952.17 Million | 100.00% |
Verano Holdings Corp Competitors by Market Cap
The table below lists competitors of Verano Holdings Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Nanjing TDH Technology Co. Ltd. A
SHE:301378
|
$158.81 Million |
|
Hangzhou Toka Ink Co. Ltd. A
SHG:688571
|
$158.83 Million |
|
Wing Tai Properties Limited
F:USH
|
$158.88 Million |
|
TASKUS INC. CL.A DL-01
F:6VY
|
$158.91 Million |
|
Anji Foodstuff Co Ltd
SHG:603696
|
$158.74 Million |
|
GeoPark Limited
SA:GPRK34
|
$158.72 Million |
|
JiangXi Tianxin Pharm Co Ltd
SHG:603235
|
$158.63 Million |
|
Paisalo Digital Limited
NSE:PAISALO
|
$158.57 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Verano Holdings Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,240,080,000 to 952,174,000, a change of -287,906,000 (-23.2%).
- Net loss of 341,859,000 reduced equity.
- Other factors increased equity by 53,953,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-341.86 Million | -35.9% |
| Other Changes | $53.95 Million | +5.67% |
| Total Change | $- | -23.22% |
Book Value vs Market Value Analysis
This analysis compares Verano Holdings Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.20x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.00 | $0.54 | x |
| 2020-12-31 | $0.00 | $0.54 | x |
| 2021-12-31 | $5.03 | $0.54 | x |
| 2022-12-31 | $4.11 | $0.54 | x |
| 2023-12-31 | $3.60 | $0.54 | x |
| 2024-12-31 | $2.67 | $0.54 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Verano Holdings Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -35.90%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -38.91%
- • Asset Turnover: 0.44x
- • Equity Multiplier: 2.09x
- Recent ROE (-35.90%) is below the historical average (-11.07%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $-68.45K |
| 2020 | 0.00% | -0.14% | 11379.28x | 0.00x | $-289.94K |
| 2021 | -0.99% | -1.99% | 0.29x | 1.72x | $-162.25 Million |
| 2022 | -20.06% | -30.61% | 0.37x | 1.79x | $-403.32 Million |
| 2023 | -9.46% | -12.50% | 0.40x | 1.87x | $-241.36 Million |
| 2024 | -35.90% | -38.91% | 0.44x | 2.09x | $-437.08 Million |
Industry Comparison
This section compares Verano Holdings Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Verano Holdings Corp (VRNOF) | $925.46 Million | 0.00% | 1.10x | $158.75 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |